[1]
Nazanin Mortazavi et al. 2023. Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis. Archives of Rheumatology. 38, 1 (Mar. 2023), 095–100. DOI:https://doi.org/10.46497/ArchRheumatol.2023.9032.